HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, Feb. 18, 2022 (HealthDay News) – Approximately one in five girls with type 2 diabetes has polycystic ovary syndrome (PCOS), according to a systematic review and meta-analysis published online Feb. 15 in JAMA Network Open.
Milena Cioana, from McMaster University in Hamilton, Ontario, Canada, and colleagues conducted a systematic literature review to determine the prevalence of PCOS in girls with type 2 diabetes and to assess the association of obesity and race with this prevalence.
Based on six studies (470 girls with type 2 diabetes), the researchers found that the prevalence of PCOS was 19.58 percent. When excluding studies that did not report PCOS diagnostic criteria, the calculated prevalence was 24.04 percent. Results should be considered with caution because of the studies that did not report the criteria used to diagnose PCOS, which is a challenge during adolescence.
"It is critical that active screening for PCOS in girls with type 2 diabetes is initiated at diabetes diagnosis and follows international evidence-based guidelines for diagnosing PCOS in adolescents," the authors write. "The associations of obesity and race with PCOS prevalence among girls with type 2 diabetes need further evaluation to help define at-risk subgroups and implement early assessment and treatment strategies to improve management of this type 2 diabetes-related comorbidity."
- Higher Event Rate of T2DM in Polycystic Ovary Syndrome ... ›
- Health Care Costs for Polycystic Ovary Syndrome High in the U.S. ... ›
- Dysglycemia Risk Up for Women With PCOS, Regardless of BMI ... ›
- Risk of Peripartum Cardiovascular Complications Up With PCOS - Consumer Health News | HealthDay ›
- Morbidity Risk Increased for Children Exposed to Maternal PCOS - Consumer Health News | HealthDay ›
- How PCOS Diagnosis Is Communicated May Affect Later Well-Being - Consumer Health News | HealthDay ›
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 23, 2022